Category Archives: Pet Stem Cell Therapy

Bioheart Labs and Stemlogix Veterinary Products Featured in Media

SUNRISE, Fla., March 22, 2012 (GLOBE NEWSWIRE) — Bioheart, Inc. (OTCBB:BHRT.OB – News), a company focused on developing stem cell therapies for heart disease, previously announced that they entered into an agreement with Stemlogix, LLC, a veterinary regenerative medicine company, to provide additional cellular products and services to the veterinary market. Under this agreement, the companies are offering stem cell banking for veterinary patients (pets). Continue reading

Posted in Pet Stem Cell Therapy | Tagged , , , , , , , , , , , | Comments Off

United Health Products Announces Distributor to the Veterinarian Market

FREEHOLD, NJ–(Marketwire -03/21/12)- United Health Products, Inc. (OTCQB: UEEC.PK – News) (Pinksheets: UEEC.PK – News), which develops and markets products and technologies in the healthcare sector, today announced that Epic Wound Care Inc., its wholly-owned subsidiary, has executed a Distribution Agreement with BioVentive Inc. Continue reading

Posted in Pet Stem Cell Therapy | Tagged , , , , , , , , , , , | Comments Off

Ocala Veterinarian Announces Free Online Veterinary Resources

OCALA, FL–(Marketwire -03/18/12)- Town & Country Animal Hospital announced that the veterinary practice has launched a new website with veterinary care resources for pet owners. The website, http://www.bestocalavet.com/, is designed to make it easy for pet owners to find accurate, reliable answers to their animal care questions Continue reading

Posted in Pet Stem Cell Therapy | Tagged , , , , , , , , , | Comments Off

Clinical Trial Findings Show Platelet Therapy Can Provide Relief for Dogs with Osteoarthritis

PORT WASHINGTON, N.Y.–(BUSINESS WIRE)– Dogs treated with platelet therapy from a unique filter-based process showed significant improvement from osteoarthritis-related pain and lameness according to a new study commissioned by Pall Corporation (NYSE: PLL). Results from the study, a two-center, prospective randomized controlled clinical trial, were revealed last night at the 39thVeterinary Orthopedic Society (VOS) Meeting in Crested Butte, Colorado. “This study is the first to provide evidence in support of platelet therapy for canine osteoarthritis, said Dr Continue reading

Posted in Pet Stem Cell Therapy | Tagged , , , , , , , | Comments Off

Pet stem cell biz booming for MediVet

In just two years after going commercial, MediVet Americas headquarters in Nicholasville has seen exponential growth with no sign of slowing down. The privately owned company is one of a handful of developers and researchers worldwide working on stem-cell regenerative therapy for animals suffering from osteoarthritis, hip dysplasia and other degenerative diseases. MediVet also provides other services such as stem-cell storage and selling stem cell extraction kits to veterinarians around the globe Continue reading

Posted in Pet Stem Cell Therapy | Tagged , , , , , , , , , , , , , | Comments Off

Warning Signs of Arthritis in Pets

Millions of Americans are living with the pain of osteoarthritis, and so are millions of pets. According to veterinarians, it’s one of the most underdiagnosed conditions in their field, and unlike their human counterparts, animals must suffer in silence. Since pets can’t express that they’re in pain, vets say there are certain warning signs owners should watch out for, ranging from physical signals to behavioral changes. Continue reading

Posted in Pet Stem Cell Therapy | Tagged , , , , , , , , | Comments Off

Novelos Therapeutics and Academic Collaborators Have Three Abstracts Accepted for Presentation at 2012 AACR Annual …

MADISON, WI–(Marketwire -03/01/12)- Novelos Therapeutics, Inc. (OTCQX: NVLT.OB – News) (OTC.BB: NVLT.OB – News), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that three scientific posters based on research conducted by Jamey Weichert, Ph.D., and his colleagues will be presented at the American Association for Cancer Research (AACR) annual meeting in April 2012 in Chicago. These presentations will describe findings in animal and cellular model systems that illustrate Novelos’ cancer-targeting technology platform and the resulting clinical-stage diapeutic agents capable of imaging and treating a wide range of malignancies. Continue reading

Posted in Pet Stem Cell Therapy | Tagged , , , , , , , , , , , , , , | Comments Off

Bestellen Sie den kostenlosen Newsletter von 4investors:

PRESS RELEASE: Two Phase III studies of Novartis drug INC424 published in NEJM show significant clinical benefit for patients with myelofibrosis Novartis International AG / Two Phase III studies of Novartis drug INC424 published in NEJM show significant clinical benefit for patients with myelofibrosis . Processed and transmitted by Thomson Reuters ONE. Continue reading

Posted in Pet Stem Cell Therapy | Tagged , , , , , , , | Comments Off

Two Phase III studies of Novartis drug INC424 published in NEJM show significant clinical benefit for patients with …

Results of the COMFORT-I and COMFORT-II trials show INC424 significantly reduced disease burden in patients with myelofibrosis Myelofibrosis is a life-threatening blood cancer associated with progressive, debilitating symptoms that severely impact quality of life and reduce survival These data provided the basis for worldwide regulatory filings with first actions expected in the second half of 2012 Basel, February 29, 2012 – The New England Journal of Medicine (NEJM) today published the results of the two Phase III trials that found treatment with the investigational Janus kinase (JAK) inhibitor INC424 (ruxolitinib) significantly reduced disease burden in patients with myelofibrosis[1],[2]. Continue reading

Posted in Pet Stem Cell Therapy | Tagged , , , , , , , , , , , | Comments Off

Irving Leads Research Co. Animal Cell Therapies

VOL. 127 | NO. Continue reading

Posted in Pet Stem Cell Therapy | Tagged , , , , , , , , , , , , , | Comments Off